Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Other Working Capital Changes (2019 - 2025)

IDEAYA Biosciences (IDYA) has disclosed Other Working Capital Changes for 7 consecutive years, with $279000.0 as the latest value for Q4 2025.

  • Quarterly Other Working Capital Changes fell 96.25% to $279000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.4 million through Dec 2025, up 52.8% year-over-year, with the annual reading at $52726.0 for FY2025, 99.14% down from the prior year.
  • Other Working Capital Changes hit $279000.0 in Q4 2025 for IDEAYA Biosciences, up from $42464.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $44.8 million in Q4 2022 to a low of -$26.3 million in Q3 2022.
  • Historically, Other Working Capital Changes has averaged -$544597.0 across 5 years, with a median of -$365500.0 in 2023.
  • Biggest five-year swings in Other Working Capital Changes: surged 782.56% in 2021 and later crashed 5325.13% in 2022.
  • Year by year, Other Working Capital Changes stood at -$23.9 million in 2021, then soared by 287.04% to $44.8 million in 2022, then crashed by 67.93% to $14.4 million in 2023, then crashed by 48.17% to $7.4 million in 2024, then plummeted by 96.25% to $279000.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for IDYA at $279000.0 in Q4 2025, $42464.0 in Q3 2025, and $34595.0 in Q2 2025.